You may be interested in these recent funding opportunity announcements (FOAs): Renewal of Centers of Biomedical Research Excellence (COBRE) (P20) (PAR-13-243) Purpose: Establish a thematic, multidisciplinary center and enhance the ability of investigators to compete independently for NIH or other external peer-reviewed support Application due dates: September 25, 2013; September 25, 2014; September 25, 2015 NIGMS contact: Yanping Liu, 301-451-4217 Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III -- Transitional Centers (P30) (PAR-13-238) Purpose: Strengthen phase I COBRE centers through improvements in research infrastructure as well as the development and support of investigators Application due date: August 2, 2013 NIGMS contact: J. Rafael Gorospe, 301-435-0832 Native American Research Centers for Health (NARCH) (S06) (PAR-13-239) Purpose: Conduct research and research training to meet the needs of American Indian/Alaska Native communities Letter of intent due date: July 6, 2013 Application due date: August 6, 2013 NIGMS contact: Sheila A. Caldwell, 301-594-3900 Reissue PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) (PA-13-234) Purpose: Research and develop innovative technologies with commercial applications* Application due date: Standard dates apply NIGMS contact: Scott Somers, 301-594-3827 Reissue PHS 2013-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42]) (PA-13-235) Purpose: Research and develop innovative technologies with commercial applications* Application due date: Standard dates apply NIGMS contact: Scott Somers, 301-594-3827 *There are important changes in the reissued SBIR/STTR FOAs, including: 1) Majority venture-capital owned companies are now eligible to apply for the NIH SBIR program; 2) All small business concerns must now register with the SBA Company Registry; and 3) NIGMS will not accept applications to the new SBIR/STTR FOAs that exceed the hard cap ($225,000 total cost for Phase I applications and $1,500,000 for Phase II applications). For more information, see the NIH SBIR/STTR Web site.